Trial Outcomes & Findings for A Pharmacist Intervention to Improve Mother and Child Health (NCT NCT06073054)
NCT ID: NCT06073054
Last Updated: 2025-08-29
Results Overview
We will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
25 participants
Primary outcome timeframe
Through study completion, an average of 30 days
Results posted on
2025-08-29
Participant Flow
Participant milestones
| Measure |
Research Pharmacist Monitoring
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Overall Study
STARTED
|
25
|
|
Overall Study
COMPLETED
|
23
|
|
Overall Study
NOT COMPLETED
|
2
|
Reasons for withdrawal
| Measure |
Research Pharmacist Monitoring
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Overall Study
Withdrawal by Subject
|
2
|
Baseline Characteristics
A Pharmacist Intervention to Improve Mother and Child Health
Baseline characteristics by cohort
| Measure |
Research Pharmacist Monitoring
n=25 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Age, Continuous
|
32.4 years
STANDARD_DEVIATION 4.8 • n=39 Participants
|
|
Sex: Female, Male
Female
|
25 Participants
n=39 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=39 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=39 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
23 Participants
n=39 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=39 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Asian
|
2 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
1 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=39 Participants
|
|
Race (NIH/OMB)
White
|
17 Participants
n=39 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=39 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=39 Participants
|
|
Education
High School
|
1 Participants
n=39 Participants
|
|
Education
Some College/Associate's
|
5 Participants
n=39 Participants
|
|
Education
Bachelor's
|
11 Participants
n=39 Participants
|
|
Education
Master's
|
6 Participants
n=39 Participants
|
|
Education
Doctoral Degree
|
2 Participants
n=39 Participants
|
PRIMARY outcome
Timeframe: Through study completion, an average of 30 daysWe will calculate the number of participants who talk to the research pharmacist during the course of the intervention.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=25 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Number of Participants Who Talk to Research Pharmacist
|
20 Participants
|
PRIMARY outcome
Timeframe: Through study completion, an average of 30 daysWe will calculate the number of participants who return at least one blood pressure measurement via text message.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=25 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Number of Participants Who Return BP Measurements
|
22 Participants
|
PRIMARY outcome
Timeframe: Through study completion, an average of 30 daysWe will calculate the percentage of well-child visits that are attended by each family.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=65 Well-child visits
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Percentage of Well-Child Visits Attended
|
57 Well-child visits
|
PRIMARY outcome
Timeframe: Through study completion, an average of 30 daysWe will calculate the percentage of vaccinations received by each child.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=300 Vaccinations
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Percentage of Vaccinations Received
|
251 Vaccinations
|
SECONDARY outcome
Timeframe: Through study completion, an average of 30 daysWe will calculate the number of blood pressure values that are submitted by each participant.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=23 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Number of BP Measurements Submitted
|
12.9 Mean Number of Blood Pressure Values
Standard Deviation 5.3
|
SECONDARY outcome
Timeframe: Through study completion, an average of 30 daysPopulation: Only 13 participants provided information on blood pressure control at the end of the study, but they did not withdraw from the study.
We will determine how many participants' blood pressure is controlled after the intervention.
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=13 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Blood Pressure Control
|
12 Participants
|
SECONDARY outcome
Timeframe: Through study completion, an average of 30 daysWe will measure participant satisfaction with the study using an exit survey. Satisfaction will be measured by a response of Extremely Helpful or Helpful on the question- My contact(s) with the pharmacist about my health were....
Outcome measures
| Measure |
Research Pharmacist Monitoring
n=11 Participants
The pharmacist will help the mother find a primary care physician if she doesn't have one, obtain health insurance if she doesn't have any, and discuss any health-related information about herself or her child, as needed. These pharmacist interactions will occur 7 days after baseline and again 1 month later (the participant will be asked to measure and text their blood pressure again 1 time per day for 3 days during the follow-up month). If the participant's blood pressures become elevated, the pharmacist will provide behavioral and lifestyle interventions to attempt to lower the blood pressure. They may also recommend medications to the participant's physician. The pharmacist will have access to the participant's electronic medical record to obtain any blood pressure-related medications that the mother is prescribed as well as throughout the follow up to ensure any health-related conditions can be discussed, as necessary.
Research Pharmacist: The goal of this intervention is to determine if contact with the research pharmacist will improve the health of the mother and/or child.
|
|---|---|
|
Number of Participants Satisfied With the Study
|
7 Participants
|
Adverse Events
Research Pharmacist Monitoring
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place